#Antidepressant_Drugs

  1. Interpersonal sensitivity and response to selective serotonin reuptake inhibitors in patients with acute major depressive disorder
  2. How do we determine whether antidepressants are useful or not?
  3. Influence of baseline severity on the effects of SSRIs in depression: An item-based, patient-level post-hoc analysis
  4. Pharmacological therapy in panic disorder: Current guidelines and novel drugs discovery for treatment-resistant patient
  5. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: A mega-analysis of citalopram and paroxetine in adult depression
  6. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment
  7. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
  8. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
  9. Evidence-based somatic treatment of depression in adults
  10. Review of The emperor's new drugs: Exploding the antidepressant myth
  11. How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low
  12. Publication bias in systematic reviews
  13. Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
  14. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis
  15. Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients
  16. Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs
  17. Placebo responses to antidepressants
  18. The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations?
  19. Placebo-controlled efficacy of antidepressants in continuation treatment